Business · 29/08/1995Updated: 10/18/2026 · 1 min read
FDA Approves IPR Pharmaceuticals' Request to Export Atenolol Bulk Drug Substance to France
Summary
The Food and Drug Administration (FDA) is announcing that IPR Pharmaceuticals, Inc., a part of Zeneca Group PLC, has filed a request with the FDA to export the bulk drug substance Atenolol to France to manufacture approved finished formulations containing Atenolol.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →